Fate Therapeutics
+$5.19 (+7.26%) Today
$0.00 (0.00%) As of 12:30 PM UTC after-hours
Why Robinhood?
You can buy or sell FATE and other stocks, options, and ETFs commission-free!
About FATE
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.
CEO
J. Scott Wolchko
Employees
279
Headquarters
San Diego, California
Founded
2007
FATE Key Statistics
Market Cap
7.87B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.36M
High Today
$78.98
Low Today
$71.40
Open Price
$71.42
Volume
1.71M
52 Week High
$121.16
52 Week Low
$26.23
Analyst Ratings
71%
of 17 ratings
Buy
70.6%
Hold
29.4%
Sell
0%
FATE Earnings
-$0.68
-$0.54
-$0.41
-$0.27
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.43 per share
Actual
-$0.48 per share